Finance

Lists
600085:SHA
Beijing Tong Ren Tang Co Ltd
24,66 CNY
+1,11%
(+0,27) 1D
14 ოქტ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600085...
Open
24,40 CNY
High
24,78 CNY
Low
24,25 CNY
Mkt. cap
33,45 მლრდ.
Avg. vol.
4,68 მლნ.
Volume
9,72 მლნ.
Dividend
2,03%
Quarterly dividend
0,12 CNY
Ex-dividend date
1 ივლ. 2026
P/E ratio
34,86
52-wk high
35,87 CNY
52-wk low
21,87 CNY
EPS
0,71 CNY
Shares outstanding
1,37 მლრდ.
No. of employees
17 ათ.
Open
24,40 CNY
High
24,78 CNY
Low
24,25 CNY
Mkt. cap
33,45 მლრდ.
Avg. vol.
4,68 მლნ.
Volume
9,72 მლნ.
Dividend
2,03%
Quarterly dividend
0,12 CNY
Ex-dividend date
1 ივლ. 2026
P/E ratio
34,86
52-wk high
35,87 CNY
52-wk low
21,87 CNY
EPS
0,71 CNY
Shares outstanding
1,37 მლრდ.
No. of employees
17 ათ.
News stories
From web sources and news partners
Profile
Tong Ren Tang is a Chinese pharmaceutical company founded in 1669. It is now the largest producer of traditional Chinese medicine. The company headquarters are in Beijing, where they engage in both manufacturing and retail sales. It operates drug stores, predominantly in Chinese-speaking regions. Tong Ren Tang is considered one of the "Big 4" traditional Chinese medicine brands still in existence. The four companies include: Guangyuyuan, Guangzhou Chen Liji, Beijing Tong Ren Tang, and Hangzhou Hu Qing Yu Tang. Tong Ren Tang, and GuangYuYuan have been officially recognized as "China Time-Honored Brands" by the Ministry of Commerce of the People's Republic of China. Wikipedia
About Beijing Tong Ren Tang Co Ltd
CEO-
Employees17,3 ათ.
Founded1669
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
3,54 მლრდ.
3,95 მლრდ.
4,66 მლრდ.
3,72 მლრდ.
Cost of goods sold
1,97 მლრდ.
2,50 მლრდ.
2,72 მლრდ.
2,17 მლრდ.
Cost of revenue
1,97 მლრდ.
2,50 მლრდ.
2,72 მლრდ.
2,17 მლრდ.
Research and development expenses
53,41 მლნ.
144,52 მლნ.
51,64 მლნ.
74,50 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,10 მლრდ.
1,30 მლრდ.
1,13 მლრდ.
1,04 მლრდ.
Operating expense
1,16 მლრდ.
1,52 მლრდ.
1,23 მლრდ.
1,16 მლრდ.
Total operating expenses
3,13 მლრდ.
4,02 მლრდ.
3,95 მლრდ.
3,33 მლრდ.
Operating income
408,67 მლნ.
-73,33 მლნ.
709,73 მლნ.
383,76 მლნ.
Other non operating income
-3,64 მლნ.
-4,50 მლნ.
-3,96 მლნ.
-4,53 მლნ.
EBT including unusual items
346,57 მლნ.
67,54 მლნ.
748,37 მლნ.
431,21 მლნ.
EBT excluding unusual items
418,62 მლნ.
-56,72 მლნ.
750,60 მლნ.
414,06 მლნ.
Income tax expense
88,79 მლნ.
27,32 მლნ.
131,64 მლნ.
112,60 მლნ.
Effective tax rate
25,62%
40,44%
17,59%
26,11%
Other operating expenses
-1,80 მლნ.
58,15 მლნ.
29,98 მლნ.
47,32 მლნ.
Net income
232,06 მლნ.
11,82 მლნ.
471,18 მლნ.
255,01 მლნ.
Net profit margin
6,56%
0,30%
10,10%
6,86%
Earnings per share
-
-
-
-
Interest and investment income
45,55 მლნ.
48,93 მლნ.
70,91 მლნ.
59,45 მლნ.
Interest expense
-30,03 მლნ.
-28,19 მლნ.
-26,08 მლნ.
-24,57 მლნ.
Net interest expenses
15,52 მლნ.
20,74 მლნ.
44,83 მლნ.
34,88 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
495,57 მლნ.
18,15 მლნ.
801,21 მლნ.
477,52 მლნ.
Gain or loss from assets sale
1,87 მლნ.
-25,11 მლნ.
-
-10,41 მლნ.
AI content may include mistakes. Learn more
Google აპები